This is a limited company view. Sign up for a Free Trial to see everything.

Madrigal Pharmaceuticals, Inc. (Nasdaq: MGDL) is a clinical-stage biopharmaceutical company pursuing novel therapeutics that target a specific thyroid hormone receptor pathway in the liver, which is a key regulatory mechanism common to a spectrum of cardio-metabolic and fatty liver diseases with high unmet medical need.

B2B
Biotechnology
Cleantech
Healthcare
Pharmaceuticals
Wind Power

Overview

Location

Boston

Founded

Employees

136

Stage

Public

Total funding

$27M

Last funding

8 years ago

Acquisitions

0

Growth score

-9

Mindshare score

0

Scoring

Deals

$3.8M Venture

Jan 19, 2010

$23.1M Venture

Jan 8, 2010

Employee Growth

Use Synta Pharmaceuticals's historical employee count to better understand their growth and spending over time.

Unlock with a Free Trial

Mobile

Use Synta Pharmaceuticals's mobile downloads and app ranks to evaluate the performance of their mobile apps.

Unlock with a Free Trial